Posted on 8/2/16
SciFluor Life Sciences Enters Clinical Trial Stage for Novel Treatment for Retinal Diseases
CAMBRIDGE, Mass.--(BUSINESS WIRE)--SciFluor Life Sciences, Inc., a clinical stage biopharmaceutical company developing a portfolio of therapeutic drugs capitalizing on the transformational power of fluorine, today announced . . .
Posted on 8/2/16
Enumeral Announces Sale of 12% Senior Secured Promissory Notes
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM), a biotechnology company focused on the discovery and development of novel antibody-based immunotherapies to help the immune system fight . . .
Posted on 8/2/16
Inotek Pharmaceuticals Announces Public Offering of $50 Million Notes
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) has commenced an underwritten public offering of $50 million aggregate principal amount of Convertible Senior Notes due 2021 (the “Notes”), . . .
Posted on 8/2/16
Bridgemedica and Alcresta Therapeutics Honored as Gold Winners in the 2016 Medical Design Excellence Award
MANSFIELD, Mass.--(BUSINESS WIRE)--Bridgemedicatoday announced that RELiZORB™ has been selected as theGold Winner in the Over-the-Counter and Self-Carecategory of the 18th Annual Medical Design Excellence Awards competition. . . .
Posted on 8/2/16
McKesson Health Solutions Awarded Patent for Healthcare Provider Management Technology
NEWTON, Mass. & KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--The United States Patent and Trademark Office has awarded U.S. Patent No. 9,269,117 to McKesson Health Solutions for proprietary . . .
Posted on 8/1/16
CycleBar Studio to Open in Fort Worth this Fall
Premium Indoor Cycling Studio, Opening October 2016, Now Accepting Applications to Join the CycleStar™ Team of Instructors CycleBar®, a new concept in premium indoor cycling that . . .
Posted on 8/1/16
Selecta Biosciences Announces Publication in Nature Nanotechnology
Published results from preclinical studies show the potential of Selecta’s proprietary SVP-Rapamycin (SEL-110) immune therapy to improve the efficacy and safety of biologic therapeutics The data . . .
Posted on 8/2/16
CEL-SCI Reports Monthly Patient Enrollment in July for Its Phase 3 Head and Neck Cancer Trial
CEL-SCI Corporation (NYSE MKT: CVM) today announced that during the month of July it has enrolled 29 patients in its ongoing Phase 3 trial of its investigational . . .
Posted on 8/1/16
Tokai Pharmaceuticals Announces Reduction in Force
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced . . .
Posted on 8/1/16
Citius Pharmaceuticals Provides Shareholder Update on Recent Achievements
Citius Pharmaceuticals, Inc. (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, today provided shareholders with . . .
Posted on 8/1/16
Emergent BioSolutions Completes Spin-Off of Aptevo Therapeutics
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed its previously announced spin-off of Aptevo Therapeutics Inc. (Nasdaq:APVO) through the distribution of all of the . . .
Posted on 8/1/16
Better Buy: Regeneron Pharmaceuticals vs. Pfizer
IMAGE SOURCE: GETTYPfizer (NYSE:PFE) and Regeneron Pharmaceuticals (NASDAQ:REGN) are both high-quality healthcare giants that have minted fortunes for their long-term shareholders. But which one of these . . .
Posted on 8/1/16
Celgene Corporation Nails the Second Quarter
IMAGE SOURCE: GETTY IMAGES.It's hard to find faults in Celgene's (NASDAQ:CELG) second-quarter earnings numbers. Revenue was up 21% year over year and adjusted earnings jumped 17% . . .
Posted on 8/1/16
Celgene's Otezla Is A Big Hit
IMAGE SOURCE: CELGENE CORPORATION.Celgene Corp (NASDAQ:CELG) launched Otezla in 2014 to diversify its revenue stream and by all measures, Celgene's first foray into autoimmune disease has . . .
Posted on 8/1/16
12 Big Pharma Stats That Will Blow You Away
IMAGE SOURCE: GETTY IMAGES.It only makes sense that Big Pharma would be associated with some big numbers. The size and reach of the major biopharmaceutical companies . . .
Posted on 8/1/16
Akcea Therapeutics Receives Orphan Designation in Europe
Akcea Therapeutics, a wholly-owned subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), announced today that the European Commission (EC) has designated volanesorsen as an orphan medicinal product . . .
Posted on 8/1/16
CVS Health to Increase Access to FDA-approved Nasal Naloxone for Patients without Insurance
CVS Health (NYSE: CVS) and Adapt Pharma (www.AdaptPharma.com) today announced a new partnership that will make the opioid overdose-reversing drug NARCAN® (Naloxone HCl) Nasal Spray more . . .
Posted on 8/1/16
AACC Launches New Journal, The Journal of Applied Laboratory Medicine
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the launch of its new journal, The . . .
Posted on 7/31/16
Optimum Healthcare IT Achieves Top Score for Consulting Services in KLAS Midterm Performance Review
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Optimum Healthcare IT, a leading healthcare IT staffing, and consulting services company, announced that it has earned the top score of 94.9 as the . . .
Posted on 7/31/16
Tokai Pharmaceuticals Announces Reduction in Force
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced . . .
Posted on 7/31/16
Southcoast Autism Center Expands
?Southcoast Autism Center, an intensive Applied Behavior Analysis center for children and families affected by Autism, will open
Posted on 7/29/16
Celgene Reports Second Quarter 2016 Operating and Financial Results
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $2,745 million for the second quarter of 2016, a 22 percent increase from the same period . . .
Posted on 7/29/16
Blink Fitness To Open Its Newest Brooklyn Location In Williamsburg
Blink Fitness, the premium-quality, value-based fitness club, is excited to announce the opening of its newest Brooklyn location in Williamsburg. The club will open the doors . . .
Posted on 7/29/16
Alexion Reports Second Quarter 2016 Results
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the second quarter of 2016. Total revenues grew to $753 million, an 18 . . .
Posted on 7/29/16
New Cancer-Focused Biotech Forty Seven Inc. Selects Medidata to Accelerate Novel Immuno-Oncology R&D
NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Forty Seven Inc., a new biotechnology . . .
